influenza A H3N2
Selected indexed studies
- Fifty Years of Influenza A(H3N2) Following the Pandemic of 1968. (Am J Public Health, 2020) [PMID:32267748]
- Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada. (Euro Surveill, 2022) [PMID:36148674]
- Lipopolysaccharide aggravates canine influenza a (H3N2) virus infection and lung damage via mTOR/autophagy in vivo and in vitro. (Food Chem Toxicol, 2023) [PMID:36596444]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Fifty Years of Influenza A(H3N2) Following the Pandemic of 1968. (2020) pubmed
- Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada. (2022) pubmed
- Lipopolysaccharide aggravates canine influenza a (H3N2) virus infection and lung damage via mTOR/autophagy in vivo and in vitro. (2023) pubmed
- Neurologic Manifestations of Influenza A(H3N2) Infection in Children During the 2016-2017 Season. (2020) pubmed
- Concomitant infections of influenza A H3N2 and disseminated cryptococcosis in a previously healthy child. (2023) pubmed
- A Bivalent Live Attenuated Influenza Virus Vaccine Protects against Drifted H1N2 and H3N2 Clinical Isolates in Swine. (2022) pubmed
- Influenza A subtype H3N2 is associated with an increased risk of hospital dissemination - an observational study over six influenza seasons. (2023) pubmed
- A large A(H3N2) influenza outbreak with a high attack rate in a drug user community in Italy, April 2022. (2023) pubmed
- The evolutionary footprint of influenza A subtype H3N2 strains in Bangladesh: implication of vaccine strain selection. (2022) pubmed
- Increased genetic variation of A(H3N2) virus from influenza surveillance at the end of the 2016/2017 season for Shanghai port, China. (2022) pubmed